Oxycodone and Isradipine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxycodone (oxycodone hydrochloride) and Isradipine (isradipine). Common drug interactions include pyrexia among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Oxycodone and Isradipine. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

What is Isradipine?

Isradipine has active ingredients of isradipine. It is often used in high blood pressure. eHealthMe is studying from 727 Isradipine users. Check the latest studies of Isradipine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

17 people who take Oxycodone and Isradipine together, and have interactions are studied.

Oxycodone and Isradipine drug interactions.

What are the common drug interactions of Oxycodone and Isradipine, by gender? *:

female:

  1. Pyrexia (fever)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Paraneoplastic syndrome (symptom that is the consequence of the presence of cancer in the body)
  6. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  7. Enterovirus infection
  8. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Platelet count decreased

male:

  1. Abdominal pain
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Rectal haemorrhage (bleeding from anus)
  4. Renal failure (kidney dysfunction)
  5. Renal impairment (severely reduced kidney function)
  6. Respiratory distress (difficulty in breathing)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Staphylococcal bacteraemia (a bacterial infection of blood)
  9. Weight decreased
  10. Bacteraemia (presence of bacteria in the blood)

What are the common drug interactions of Oxycodone and Isradipine, by age (0-1 to 60+)? *:

0-1:

  1. Extravasation (leakage of a fluid)
  2. Infusion site pain
  3. Infusion site swelling

2-9:

  1. Pyrexia (fever)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  4. Leukaemia recurrent (repeat cancer of bone marrow or blood cells)

10-19:

  1. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Pyrexia (fever)
  5. Paraneoplastic syndrome (symptom that is the consequence of the presence of cancer in the body)
  6. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  7. Enterovirus infection
  8. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Platelet count decreased

20-29:

  1. Abdominal pain
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Diarrhoea
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  6. Renal failure (kidney dysfunction)
  7. Renal impairment (severely reduced kidney function)
  8. Respiratory distress (difficulty in breathing)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Staphylococcal bacteraemia (a bacterial infection of blood)

30-39:

n/a

40-49:

  1. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  2. Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
  3. Adenovirus infection
  4. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  5. Graft versus host disease in liver (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the liver)
  6. Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
  7. Lactic acidosis (low ph in body tissues)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Septic shock (shock due to blood infection)
  10. Ascites (accumulation of fluid in the abdominal cavity)

50-59:

n/a

60+:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Bacteraemia (presence of bacteria in the blood)
  3. Dyspnoea (difficult or laboured respiration)
  4. Rectal haemorrhage (bleeding from anus)

What are the existing conditions these people have? *

  1. Constipation: 7 people, 41.18%
  2. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 7 people, 41.18%
  3. Viral Infection: 6 people, 35.29%
  4. Flatulence (flatus expelled through the anus): 6 people, 35.29%
  5. Bacterial Infection: 6 people, 35.29%
  6. Lip Dry: 6 people, 35.29%
  7. Neuralgia (pain in one or more nerves): 6 people, 35.29%
  8. Sleep Disorder: 6 people, 35.29%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 35.29%
  10. Fungal Infection: 6 people, 35.29%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone and Isradipine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oxycodone and Isradipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isradipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isradipine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride and isradipine (the active ingredients of Oxycodone and Isradipine, respectively), and Oxycodone and Isradipine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: